Selected research
Industry Research
Medical Bioactive Glass Industry Research Report 2026
Market perspective
The global Medical Bioactive Glass market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Medical Bioactive Glass is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Medical Bioactive Glass is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Medical Bioactive Glass is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Medical Bioactive Glass include Zimmer Biomet Holdings, Inc., Stryker, SCHOTT, BonAlive Biomaterials, NovaBone, Beijing Xinfuyisheng High Technology, Prosidyan, Ferro and Mo-Sci Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Medical Bioactive Glass market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Medical Bioactive Glass Market by Company
Zimmer Biomet Holdings, Inc.
Stryker
SCHOTT
BonAlive Biomaterials
NovaBone
Beijing Xinfuyisheng High Technology
Prosidyan
Ferro
Mo-Sci Corporation
Synergy Biomedical
3M
Matexcel
Noraker
Ugulin
Kunshan Overseas Chinese Technology New Materials
Zhangjiagang Lanzhi Biotechnology
Guangzhou Kejin Material Technology
Medical Bioactive Glass Segment by Type
45S5
S53P4
Others
Medical Bioactive Glass Segment by Application
Bone Materials
Dental Materials
Cosmetics
Medical Bioactive Glass Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Bioactive Glass market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Bioactive Glass and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Bioactive Glass.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Medical Bioactive Glass manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Medical Bioactive Glass by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Medical Bioactive Glass in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 45S5
- S53P4
- Others
Applications
- Bone Materials
- Dental Materials
- Cosmetics
Companies covered
- Zimmer Biomet Holdings, Inc.
- Stryker
- SCHOTT
- BonAlive Biomaterials
- NovaBone
- Beijing Xinfuyisheng High Technology
- Prosidyan
- Ferro
- Mo-Sci Corporation
- Synergy Biomedical
- 3M
- Matexcel
- Noraker
- Ugulin
- Kunshan Overseas Chinese Technology New Materials
- Zhangjiagang Lanzhi Biotechnology
- Guangzhou Kejin Material Technology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Medical Bioactive Glass Market Size (2021-2032)
- 2.2.2 Global Medical Bioactive Glass Sales (2021-2032)
- 2.2.3 Global Medical Bioactive Glass Market Average Price (2021-2032)
- 2.3 Medical Bioactive Glass by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 45S5
- 2.3.3 S53P4
- 2.3.4 Others
- 2.4 Medical Bioactive Glass by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Bone Materials
- 2.4.3 Dental Materials
- 2.4.4 Cosmetics
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Medical Bioactive Glass Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Medical Bioactive Glass Sales (Kg) of Manufacturers (2021-2026)
- 3.3 Global Medical Bioactive Glass Revenue of Manufacturers (2021-2026)
- 3.4 Global Medical Bioactive Glass Average Price by Manufacturers (2021-2026)
- 3.5 Global Medical Bioactive Glass Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Medical Bioactive Glass, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Medical Bioactive Glass, Product Type & Application
- 3.8 Global Manufacturers of Medical Bioactive Glass, Established Date
- 3.9 Global Medical Bioactive Glass Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zimmer Biomet Holdings, Inc.
- 4.1.1 Zimmer Biomet Holdings, Inc. Company Information
- 4.1.2 Zimmer Biomet Holdings, Inc. Business Overview
- 4.1.3 Zimmer Biomet Holdings, Inc. Medical Bioactive Glass Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zimmer Biomet Holdings, Inc. Medical Bioactive Glass Product Portfolio
- 4.1.5 Zimmer Biomet Holdings, Inc. Recent Developments
- 4.2 Stryker
- 4.2.1 Stryker Company Information
- 4.2.2 Stryker Business Overview
- 4.2.3 Stryker Medical Bioactive Glass Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Stryker Medical Bioactive Glass Product Portfolio
- 4.2.5 Stryker Recent Developments
- 4.3 SCHOTT
- 4.3.1 SCHOTT Company Information
- 4.3.2 SCHOTT Business Overview
- 4.3.3 SCHOTT Medical Bioactive Glass Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 SCHOTT Medical Bioactive Glass Product Portfolio
- 4.3.5 SCHOTT Recent Developments
- 4.4 BonAlive Biomaterials
- 4.4.1 BonAlive Biomaterials Company Information
- 4.4.2 BonAlive Biomaterials Business Overview
- 4.4.3 BonAlive Biomaterials Medical Bioactive Glass Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 BonAlive Biomaterials Medical Bioactive Glass Product Portfolio
- 4.4.5 BonAlive Biomaterials Recent Developments
- 4.5 NovaBone
- 4.5.1 NovaBone Company Information
- 4.5.2 NovaBone Business Overview
- 4.5.3 NovaBone Medical Bioactive Glass Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 NovaBone Medical Bioactive Glass Product Portfolio
- 4.5.5 NovaBone Recent Developments
- 4.6 Beijing Xinfuyisheng High Technology
- 4.6.1 Beijing Xinfuyisheng High Technology Company Information
- 4.6.2 Beijing Xinfuyisheng High Technology Business Overview
- 4.6.3 Beijing Xinfuyisheng High Technology Medical Bioactive Glass Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Beijing Xinfuyisheng High Technology Medical Bioactive Glass Product Portfolio
- 4.6.5 Beijing Xinfuyisheng High Technology Recent Developments
- 4.7 Prosidyan
- 4.7.1 Prosidyan Company Information
- 4.7.2 Prosidyan Business Overview
- 4.7.3 Prosidyan Medical Bioactive Glass Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Prosidyan Medical Bioactive Glass Product Portfolio
- 4.7.5 Prosidyan Recent Developments
- 4.8 Ferro
- 4.8.1 Ferro Company Information
- 4.8.2 Ferro Business Overview
- 4.8.3 Ferro Medical Bioactive Glass Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Ferro Medical Bioactive Glass Product Portfolio
- 4.8.5 Ferro Recent Developments
- 4.9 Mo-Sci Corporation
- 4.9.1 Mo-Sci Corporation Company Information
- 4.9.2 Mo-Sci Corporation Business Overview
- 4.9.3 Mo-Sci Corporation Medical Bioactive Glass Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Mo-Sci Corporation Medical Bioactive Glass Product Portfolio
- 4.9.5 Mo-Sci Corporation Recent Developments
- 4.10 Synergy Biomedical
- 4.10.1 Synergy Biomedical Company Information
- 4.10.2 Synergy Biomedical Business Overview
- 4.10.3 Synergy Biomedical Medical Bioactive Glass Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Synergy Biomedical Medical Bioactive Glass Product Portfolio
- 4.10.5 Synergy Biomedical Recent Developments
- 4.11 3M
- 4.11.1 3M Company Information
- 4.11.2 3M Business Overview
- 4.11.3 3M Medical Bioactive Glass Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 3M Medical Bioactive Glass Product Portfolio
- 4.11.5 3M Recent Developments
- 4.12 Matexcel
- 4.12.1 Matexcel Company Information
- 4.12.2 Matexcel Business Overview
- 4.12.3 Matexcel Medical Bioactive Glass Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Matexcel Medical Bioactive Glass Product Portfolio
- 4.12.5 Matexcel Recent Developments
- 4.13 Noraker
- 4.13.1 Noraker Company Information
- 4.13.2 Noraker Business Overview
- 4.13.3 Noraker Medical Bioactive Glass Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Noraker Medical Bioactive Glass Product Portfolio
- 4.13.5 Noraker Recent Developments
- 4.14 Ugulin
- 4.14.1 Ugulin Company Information
- 4.14.2 Ugulin Business Overview
- 4.14.3 Ugulin Medical Bioactive Glass Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Ugulin Medical Bioactive Glass Product Portfolio
- 4.14.5 Ugulin Recent Developments
- 4.15 Kunshan Overseas Chinese Technology New Materials
- 4.15.1 Kunshan Overseas Chinese Technology New Materials Company Information
- 4.15.2 Kunshan Overseas Chinese Technology New Materials Business Overview
- 4.15.3 Kunshan Overseas Chinese Technology New Materials Medical Bioactive Glass Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Kunshan Overseas Chinese Technology New Materials Medical Bioactive Glass Product Portfolio
- 4.15.5 Kunshan Overseas Chinese Technology New Materials Recent Developments
- 4.16 Zhangjiagang Lanzhi Biotechnology
- 4.16.1 Zhangjiagang Lanzhi Biotechnology Company Information
- 4.16.2 Zhangjiagang Lanzhi Biotechnology Business Overview
- 4.16.3 Zhangjiagang Lanzhi Biotechnology Medical Bioactive Glass Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Zhangjiagang Lanzhi Biotechnology Medical Bioactive Glass Product Portfolio
- 4.16.5 Zhangjiagang Lanzhi Biotechnology Recent Developments
- 4.17 Guangzhou Kejin Material Technology
- 4.17.1 Guangzhou Kejin Material Technology Company Information
- 4.17.2 Guangzhou Kejin Material Technology Business Overview
- 4.17.3 Guangzhou Kejin Material Technology Medical Bioactive Glass Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Guangzhou Kejin Material Technology Medical Bioactive Glass Product Portfolio
- 4.17.5 Guangzhou Kejin Material Technology Recent Developments
5 Global Medical Bioactive Glass Market Scenario by Region
- 5.1 Global Medical Bioactive Glass Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Medical Bioactive Glass Sales by Region: 2021-2032
- 5.2.1 Global Medical Bioactive Glass Sales by Region: 2021-2026
- 5.2.2 Global Medical Bioactive Glass Sales by Region: 2027-2032
- 5.3 Global Medical Bioactive Glass Revenue by Region: 2021-2032
- 5.3.1 Global Medical Bioactive Glass Revenue by Region: 2021-2026
- 5.3.2 Global Medical Bioactive Glass Revenue by Region: 2027-2032
- 5.4 North America Medical Bioactive Glass Market Facts & Figures by Country
- 5.4.1 North America Medical Bioactive Glass Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Medical Bioactive Glass Sales by Country (2021-2032)
- 5.4.3 North America Medical Bioactive Glass Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Medical Bioactive Glass Market Facts & Figures by Country
- 5.5.1 Europe Medical Bioactive Glass Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Medical Bioactive Glass Sales by Country (2021-2032)
- 5.5.3 Europe Medical Bioactive Glass Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Medical Bioactive Glass Market Facts & Figures by Country
- 5.6.1 Asia Pacific Medical Bioactive Glass Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Medical Bioactive Glass Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Medical Bioactive Glass Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Medical Bioactive Glass Market Facts & Figures by Country
- 5.7.1 South America Medical Bioactive Glass Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Medical Bioactive Glass Sales by Country (2021-2032)
- 5.7.3 South America Medical Bioactive Glass Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Medical Bioactive Glass Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Medical Bioactive Glass Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Medical Bioactive Glass Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Medical Bioactive Glass Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Medical Bioactive Glass Sales by Type (2021-2032)
- 6.1.1 Global Medical Bioactive Glass Sales by Type (2021-2032) & (Kg)
- 6.1.2 Global Medical Bioactive Glass Sales Market Share by Type (2021-2032)
- 6.2 Global Medical Bioactive Glass Revenue by Type (2021-2032)
- 6.2.1 Global Medical Bioactive Glass Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Medical Bioactive Glass Revenue Market Share by Type (2021-2032)
- 6.3 Global Medical Bioactive Glass Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Medical Bioactive Glass Sales by Application (2021-2032)
- 7.1.1 Global Medical Bioactive Glass Sales by Application (2021-2032) & (Kg)
- 7.1.2 Global Medical Bioactive Glass Sales Market Share by Application (2021-2032)
- 7.2 Global Medical Bioactive Glass Revenue by Application (2021-2032)
- 7.2.1 Global Medical Bioactive Glass Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Medical Bioactive Glass Revenue Market Share by Application (2021-2032)
- 7.3 Global Medical Bioactive Glass Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Medical Bioactive Glass Value Chain Analysis
- 8.1.1 Medical Bioactive Glass Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Medical Bioactive Glass Production Mode & Process
- 8.2 Medical Bioactive Glass Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Medical Bioactive Glass Distributors
- 8.2.3 Medical Bioactive Glass Customers
9 Global Medical Bioactive Glass Analyzing Market Dynamics
- 9.1 Medical Bioactive Glass Industry Trends
- 9.2 Medical Bioactive Glass Industry Drivers
- 9.3 Medical Bioactive Glass Industry Opportunities and Challenges
- 9.4 Medical Bioactive Glass Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst